drugset
drugset / Trial / NCT00457106

A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks

NCT00457106 ↗

Completed 90 enrolled Beth Israel Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

This study compares the efficacy of risperidone to that of paroxetine in the treatment of panic attacks in patients with Panic Disorder and with Major Depressive Disorder with Panic attacks and compares the side effect profile of risperidone vs. paroxetine in treatment of panic attacks and compares response rates of risperidone vs. paroxetine in treatment of panic attacks.

Timeline

Start
2002-06
Primary completion
2003-06
Completion
2003-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Paroxetine Small molecule 5 mg Oral
Subject Paroxetine Small molecule 10 mg Oral
Subject Paroxetine Small molecule 20 mg Oral
Subject Paroxetine Small molecule 30 mg Oral
Subject Paroxetine Small molecule 40 mg Oral
Subject Risperidone Other / unclassified 0.125 mg Oral
Subject Risperidone Other / unclassified 0.25 mg Oral
Subject Risperidone Other / unclassified 0.5 mg Oral

Indications

major depressive disorder panic disorder